Greenland Mines Ltd (GRML) stock
GRMLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as GRMLW
$2.99+0.08 (+2.75%)
Close on Nov 20, 2026Market cap $40.92MP/E –Yield –
Greenland Mines operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Greenland Mines's operating income for the twelve months ending Sep 30, 2026 was -$29.23M. For fiscal 2025 it was -$7.15M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.15M | – |
| FY2024 | Dec 31, 2024 | -$5.54M | – |
| FY2023 | Dec 31, 2023 | -$631.32K | – |
| FY2022 | Dec 31, 2022 | -$657.02K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$12.41M | – |
| Q2 FY2026 | Jun 30, 2026 | -$5.49M | – |
| Q1 FY2026 | Mar 31, 2026 | -$9.51M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.85M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.89M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.59M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.85M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.87M | – |
| Q2 FY2024 | Jun 30, 2024 | -$395.61K | – |
| Q1 FY2024 | Mar 31, 2024 | -$672.05K | – |
| Q4 FY2023 | Dec 31, 2023 | -$110.73K | – |
| Q3 FY2023 | Sep 30, 2023 | -$123.74K | – |
| Q2 FY2023 | Jun 30, 2023 | -$244.25K | – |
| Q1 FY2023 | Mar 31, 2023 | -$325.75K | – |
| Q4 FY2022 | Dec 31, 2022 | -$239.54K | – |
| Q3 FY2022 | Sep 30, 2022 | -$179.73K | – |
| Q2 FY2022 | Jun 30, 2022 | -$232.74K | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.01K | – |
| Q3 FY2021 | Sep 30, 2021 | -$16 | – |
See a number that looks wrong?